Cargando…
FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells
BACKGROUND: Surgical procedures such as liver resection and liver transplantation are the first-line treatments for hepatocellular carcinoma (HCC) patients. However, the high incidence of tumor recurrence and metastasis after liver surgery remains a major problem. Recent studies have shown that hepa...
Autores principales: | Li, Chang Xian, Shao, Yan, Ng, Kevin T. P., Liu, Xiao Bing, Ling, Chang Chun, Ma, Yuen Yuen, Geng, Wei, Fan, Sheung Tat, Lo, Chung Mau, Man, Kwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288101/ https://www.ncbi.nlm.nih.gov/pubmed/22384233 http://dx.doi.org/10.1371/journal.pone.0032380 |
Ejemplares similares
-
FTY720 Suppresses Liver Tumor Growth and Metastasis by Reducing Circulating Regulating T Cells and Enhancing the Anti-Tumor Effect of Rapamycin
por: Li, Chang Xian, et al.
Publicado: (2020) -
FTY720-derivatives do not induce FTY720-like lymphopenia
por: Segura-Ulate, Ismael, et al.
Publicado: (2017) -
A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells
por: Li, Chang Xian, et al.
Publicado: (2014) -
FTY720 attenuates excitotoxicity and neuroinflammation
por: Cipriani, Raffaela, et al.
Publicado: (2015) -
FTY720 restores endothelial cell permeability induced by malaria sera
por: Oggungwan, Karanyaporn, et al.
Publicado: (2018)